Fenwick & West LLP advised KaliVir Immunotherapeutics on the deal. KaliVir Immunotherapeutics, an early stage biotech company developing cutting-edge, next-generation oncolytic viral immunotherapy programs, in its…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
